Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is International Seaways INSW stock volatile Q4 2025 Earnings Beat Estimates DOUG Doug Elliman shares tumble 33 after EPS misses by 655 though revenue grows 38 YoY What would it take for Ashland ASH to double from here 024 20260508 USIO Usio posts steep Q4 2025 earnings miss but investor sentiment pushes shares slightly higher ZipRecruiter ZIP Slides 567 as Job Market Headwinds Weigh on Shares Velo3D VELO Stock Today Drops 259 Key Support at 1572 20260520 AORT Q1 2026 Earnings EPS Misses Estimates as Company Advances Strategic Initiatives SU Group SUGP Stock Today Drops 940 Key Support at 458 20260520 US Fiscal Woes Deepen as Bond Market Rout Fuels Deficit Concerns Berkshire Hathaway Returns to Airlines with 26 Billion Delta Stake Jardine Matheson Expands Healthcare Footprint with A34 Billion Acquisition of IMED Radiology Network Meta Rolls Out AI Subscription Plans Starting at 799 Monthly in New Testing Phase Piper Sandler Warns Strait of Hormuz Closure Could Drive Oil to New Highs This Summer SP 500 Holds Near Flat as Consumer Stocks Rally Energy Slumps Revolve Group Inc RVLV Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick Amid Quiet Revenue Picture Shoulder Innovations Inc SI Q1 2026 Earnings Narrower Loss Beats Estimates Despite Revenue Uncertainty SWAG Q1 2026 Earnings Positive EPS Amid Limited Disclosure aka Brands Holding Corp AKA Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Uptick XRN Q1 2026 Earnings Significant EPS Miss Amid Challenging Real Estate Conditions ICG Q4 2025 Earnings Massive EPS Miss Shakes Investor Confidence Baozun Inc BZUN Dips 27 as Shares Approach Key Support Level PagerDuty Inc PD Rallies 327 as Stock Nears Key Resistance Level Hershey HSY Hovers Near Support as Confectionary Giant Faces Modest Pullback Gladstone Investment Notes GAING Hold Steady at 2532 as Market Awaits Rate Clarity Codexis CDXS Slides 158 as Biotech Stock Tests Key Support at 237